A walk down a 5-kilometer road in Miraj, a mid-sized regional town in India’s western state of Maharashtra, offers a clear snapshot of a seismic shift reshaping India’s healthcare landscape: more than 50 new multi-specialty hospitals, diagnostic hubs and private clinics line the route, almost all built in just the last five years. This proliferation of private care facilities is far from an isolated trend. It is the visible marker of an unprecedented boom that has swept India’s private healthcare industry over the past decade, transforming access to care while sparking urgent debate over systemic inequality and affordability.
Across the country, private hospital groups are expanding at breakneck speed, adding thousands of new beds every quarter to meet rising demand. Diagnostic chains are rapidly extending their reach into tier-2 and tier-3 towns that were long underserved by formal healthcare, while leading medical institutions are tapping public markets to raise hundreds of millions of dollars for nationwide expansion. In early August 2026, Manipal Health, India’s largest multi-specialty hospital chain, pulled in nearly $1 billion through an initial public offering (IPO), marking the country’s second-biggest public market debut of the year.
Global private equity investors have also flocked to the sector, lured by India’s growing demand for healthcare as incomes rise and chronic disease rates increase. Data from consulting firm Grant Thornton shows that between 2022 and 2024, Indian healthcare and pharmaceutical companies closed nearly 600 merger and acquisition (M&A) and private equity deals worth a combined $30 billion. Forty percent of that total investment went directly to hospital operators, and the BBC’s analysis of additional Grant Thornton data reveals the sector has raised a further $20 billion in just the past two years.
While this wave of investment has dramatically expanded the overall availability of healthcare infrastructure across India, it has also pushed life-saving care out of reach for millions of low- and middle-income citizens, deepening a national affordability crisis that has sparked alarm among policymakers and public health experts. A new government advisory panel report has laid bare the stark inequality at the heart of India’s fast-growing private healthcare economy, warning that unregulated growth is leaving vulnerable households at severe financial risk.
The panel’s analysis found that the cost of treatment at private hospitals is typically 5 to 10 times higher than at comparable public sector facilities. The gap grows even wider for patients battling high-cost chronic and critical illnesses including cancer, heart disease and kidney failure. The report also points out that unbridled expansion of small clinics, nursing homes and diagnostic centers, paired with inconsistent enforcement of national regulatory standards, has created huge disparities in both care quality and pricing across the private sector. This lack of oversight leaves patients exposed to arbitrary pricing and widespread substandard care practices.
Rampant commercialization of private healthcare, the report adds, has driven a surge in patient complaints over excessive billing, unnecessary diagnostic testing, and exorbitant costs for routine procedures such as childbirth. These inflated costs are directly pushing vulnerable households into catastrophic, life-altering debt, forcing many to sell assets or deplete decades of savings to cover medical bills. The crisis of unregulated pricing was highlighted earlier this month when Maharashtra’s food and drug regulator discovered that private hospitals in the state were selling intravenous (IV) fluid sets with a staggering profit margin of 2,800%, a mark-up that regulators noted is almost entirely unmonitored under current rules.
To address these systemic gaps, the government panel has put forward a sweeping set of policy recommendations, including several highly contentious proposals. Among the most debated ideas are a cap on private hospital room rates capped at the average rate of a local three-star hotel, mandatory price regulation for essential treatments, diagnostic services and routine procedures across all private facilities, and enforced standard treatment guidelines to cut down on unnecessary over-treatment. The panel also issued a red flag over foreign ownership exceeding 51% of large domestic hospital chains.
India’s private healthcare industry has pushed back aggressively against many of these proposals, arguing that price caps will stifle future investment and slow the expansion of much-needed care capacity. In an official statement to the BBC, Siddhartha Bhattacharya, Secretary General of NATHEALTH, the leading industry association for India’s private healthcare sector, said policymakers should focus on cutting structural costs that drive up care prices including high taxes, expensive land, costly capital, strict regulatory compliance fees and high skilled labor costs, rather than imposing arbitrary rate caps.
Bhattacharya noted that healthcare delivery is an extremely capital-intensive and investment-heavy sector, with return on capital employed hovering around just 10% — far lower than the 15-25% returns common in many other sectors of the Indian economy. He also rejected the comparison of hospital room pricing to three-star hotel rates, arguing that the analogy overlooks the costly mandatory compliance standards that hospitals must meet, including rigorous infection control protocols and patient safety requirements that add significantly to operating costs.
Leaders of India’s largest hospital chains, including Max Healthcare and Fortis, have echoed these concerns, warning that arbitrary price caps will drive away domestic and foreign investors alike, who will exit the market if they cannot guarantee fair returns on the large upfront capital investments required to build and operate hospitals.
Despite industry pushback, public health experts argue that price regulation is a necessary intervention, noting that India’s private healthcare market currently operates entirely as an unregulated seller’s market that gives providers near-total control over pricing. “With large amounts of foreign private equity flowing into the sector, especially for advanced tertiary care, pricing decisions are increasingly being made by stakeholders outside of India, and that is not a sustainable model,” Dr. Srinath Reddy, president of the Public Health Foundation of India, told the BBC.
Vivek ND, a leading New Delhi-based health policy expert, added that government intervention is particularly critical given the super-sized profits many large hospital chains are currently earning from unregulated pricing. “The growing trend of hospitals pushing patients to undergo dozens of unnecessary tests and unneeded procedures needs urgent scrutiny,” he noted. Vivek welcomed some of the panel’s more moderate proposals, such as a restructuring of India’s goods and services tax regime to lower costs for healthcare providers and patients, but called for broad consultations with all stakeholders before any binding policy changes are implemented.
Dr. Reddy echoed that view, noting that before any blanket price caps are imposed, policymakers need to conduct full nationwide surveys to calculate the actual cost of delivering private care across different regions. “Healthcare costs vary widely from state to state and between large cities and small towns, so a one-size-fits-all national cap simply will not work,” he explained.
As the debate over regulation heats up, public health experts across the board agree that the long-term solution to India’s healthcare affordability crisis lies in drastically expanding public sector healthcare capacity to reduce citizen dependence on expensive private facilities. This is a core recommendation of the government panel’s report itself.
Currently, India’s central government spends just 1.4% of its gross domestic product (GDP) on public healthcare, falling far short of the 2.5% target set out in the National Health Policy nearly a decade ago, and a fraction of the 5% of GDP the World Health Organization recommends as a minimum for strong public health systems. The government panel’s report notes that chronically underinvestment in public secondary and tertiary care has pushed millions of Indians to seek care from private facilities, leading to the catastrophic out-of-pocket health spending that pushes 6 million Indians into poverty every year, according to World Bank data.
“The Indian government has to step up its investment in public healthcare dramatically to reduce the ordinary person’s dependence on private hospitals,” Vivek said. Yet policymakers face a difficult balancing act: estimates show India needs an additional $300 billion in healthcare investment over the next decade to meet growing demand for care, and the vast majority of that capital will have to come from private domestic and foreign investors.
That leaves policymakers with the unenviable task of crafting regulation that protects ordinary patients from exploitative pricing without driving away the investment India needs to expand overall care capacity. The outcome of this debate will shape the health and financial security of hundreds of millions of Indians for decades to come.
